Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial

Author(s):  
Taku Kobayashi ◽  
Satoshi Motoya ◽  
Shiro Nakamura ◽  
Takayuki Yamamoto ◽  
Masakazu Nagahori ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document